|
|||||
|
|
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia |
|
| Authors: | Irene M. Ghobrial Wanling Xie Swaminathan Padmanabhan Ashraf Badros Meghan Rourke Renee Leduc Stacey Chuma Janet Kunsman Diane Warren Tiffany Poon Brianna Harris Amy Sam Kenneth C. Anderson Paul G. Richardson Steven P. Treon Edie Weller Jeffrey Matous |
| Affiliation: | 1. Dana‐Farber Cancer Institute, Boston, Massachusetts;2. Roswell Park Cancer Center, Buffalo, New York;3. University of Maryland, Greenebeum Cencer Center, Baltimore, Maryland;4. Rocky Mountain Cancer Center, Denver, Colorado |
| Abstract: | |
| Keywords: | |